200 related articles for article (PubMed ID: 18394008)
21. Colocalization of tau and alpha-synuclein epitopes in Lewy bodies.
Ishizawa T; Mattila P; Davies P; Wang D; Dickson DW
J Neuropathol Exp Neurol; 2003 Apr; 62(4):389-97. PubMed ID: 12722831
[TBL] [Abstract][Full Text] [Related]
22. TIGAR inclusion pathology is specific for Lewy body diseases.
López KLR; Simpson JE; Watson LC; Mortiboys H; Hautbergue GM; Bandmann O; Highley JR
Brain Res; 2019 Mar; 1706():218-223. PubMed ID: 30267647
[TBL] [Abstract][Full Text] [Related]
23. Synchrotron FTIR micro-spectroscopy for structural analysis of Lewy bodies in the brain of Parkinson's disease patients.
Araki K; Yagi N; Ikemoto Y; Yagi H; Choong CJ; Hayakawa H; Beck G; Sumi H; Fujimura H; Moriwaki T; Nagai Y; Goto Y; Mochizuki H
Sci Rep; 2015 Dec; 5():17625. PubMed ID: 26621077
[TBL] [Abstract][Full Text] [Related]
24. Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry.
Braak H; Sandmann-Keil D; Gai W; Braak E
Neurosci Lett; 1999 Apr; 265(1):67-9. PubMed ID: 10327208
[TBL] [Abstract][Full Text] [Related]
25. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].
Iwatsubo T
Rinsho Shinkeigaku; 1999 Dec; 39(12):1285-6. PubMed ID: 10791099
[TBL] [Abstract][Full Text] [Related]
26. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.
Baba M; Nakajo S; Tu PH; Tomita T; Nakaya K; Lee VM; Trojanowski JQ; Iwatsubo T
Am J Pathol; 1998 Apr; 152(4):879-84. PubMed ID: 9546347
[TBL] [Abstract][Full Text] [Related]
27. Progressive accumulation of ubiquitin and disappearance of alpha-synuclein epitope in multiple system atrophy-associated glial cytoplasmic inclusions: triple fluorescence study combined with Gallyas-Braak method.
Sakamoto M; Uchihara T; Nakamura A; Mizutani T; Mizusawa H
Acta Neuropathol; 2005 Oct; 110(4):417-25. PubMed ID: 16133540
[TBL] [Abstract][Full Text] [Related]
28. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
Orimo S
Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627
[TBL] [Abstract][Full Text] [Related]
29. Positive immunoreactivity for vesicular monoamine transporter 2 in Lewy bodies and Lewy neurites in substantia nigra.
Yamamoto S; Fukae J; Mori H; Mizuno Y; Hattori N
Neurosci Lett; 2006 Apr; 396(3):187-91. PubMed ID: 16386370
[TBL] [Abstract][Full Text] [Related]
30. Cell type specific sequestration of choline acetyltransferase and tyrosine hydroxylase within Lewy bodies.
Dugger BN; Dickson DW
Acta Neuropathol; 2010 Nov; 120(5):633-9. PubMed ID: 20721565
[TBL] [Abstract][Full Text] [Related]
31. Do Lewy bodies contain alpha-synuclein fibrils? and Does it matter? A brief history and critical analysis of recent reports.
Lashuel HA
Neurobiol Dis; 2020 Jul; 141():104876. PubMed ID: 32339655
[TBL] [Abstract][Full Text] [Related]
32. Lewy body-type degeneration in cardiac plexus in Parkinson's and incidental Lewy body diseases.
Iwanaga K; Wakabayashi K; Yoshimoto M; Tomita I; Satoh H; Takashima H; Satoh A; Seto M; Tsujihata M; Takahashi H
Neurology; 1999 Apr; 52(6):1269-71. PubMed ID: 10214756
[TBL] [Abstract][Full Text] [Related]
33. Abnormal distribution of the non-Abeta component of Alzheimer's disease amyloid precursor/alpha-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment.
Takeda A; Hashimoto M; Mallory M; Sundsumo M; Hansen L; Sisk A; Masliah E
Lab Invest; 1998 Sep; 78(9):1169-77. PubMed ID: 9759660
[TBL] [Abstract][Full Text] [Related]
34. Expression of α-synuclein is regulated in a neuronal cell type-dependent manner.
Taguchi K; Watanabe Y; Tsujimura A; Tanaka M
Anat Sci Int; 2019 Jan; 94(1):11-22. PubMed ID: 30362073
[TBL] [Abstract][Full Text] [Related]
35. Alpha-synuclein immunoreactive Lewy bodies and Lewy neurites in Parkinson's disease are detectable by an advanced silver-staining technique.
Sandmann-Keil D; Braak H; Okochi M; Haass C; Braak E
Acta Neuropathol; 1999 Nov; 98(5):461-4. PubMed ID: 10541868
[TBL] [Abstract][Full Text] [Related]
36. An order in Lewy body disorders: Retrograde degeneration in hyperbranching axons as a fundamental structural template accounting for focal/multifocal Lewy body disease.
Uchihara T
Neuropathology; 2017 Apr; 37(2):129-149. PubMed ID: 27862327
[TBL] [Abstract][Full Text] [Related]
37. Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease.
Mezey E; Dehejia AM; Harta G; Tresser N; Suchy SF; Nussbaum RL; Brownstein MJ; Polymeropoulos MH
Mol Psychiatry; 1998 Nov; 3(6):493-9. PubMed ID: 9857974
[TBL] [Abstract][Full Text] [Related]
38. NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease.
Wakabayashi K; Matsumoto K; Takayama K; Yoshimoto M; Takahashi H
Neurosci Lett; 1997 Dec; 239(1):45-8. PubMed ID: 9547168
[TBL] [Abstract][Full Text] [Related]
39. α-Synuclein aggregation and transmission in Parkinson's disease: a link to mitochondria and lysosome.
Wang R; Sun H; Ren H; Wang G
Sci China Life Sci; 2020 Dec; 63(12):1850-1859. PubMed ID: 32681494
[TBL] [Abstract][Full Text] [Related]
40. Lewy bodies in Betz cells of the motor cortex in a patient with Parkinson's disease.
Wakabayashi K; Mori F; Oyama Y; Kurihara A; Kamada M; Yoshimoto M; Takahashi H
Acta Neuropathol; 2003 Feb; 105(2):189-92. PubMed ID: 12536231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]